First in-body CRISPR human trial targets hereditary blindness
The CRISPR gene-editing tool has been used inside the human body for the first time. In a new clinical trial, scientists at the Oregon Health and Science University (OHSU) are testing the technique as a treatment for a genetic mutation that causes blin… Continue reading First in-body CRISPR human trial targets hereditary blindness